BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prozac
,
rs7903146
,
DNMT1
,
Response to oxidative stress
,
Breast Cancer
,
Heart
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Clear cell renal cell carcinoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
SLC12A1
UMOD
ALDOB
KNG1
CALB1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN
RODWELL_AGING_KIDNEY_UP
MODULE_84
vesicle
CHEN_METABOLIC_SYNDROM_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Clear cell renal cell carcinoma cells with MBNL2 shRNA knockdown
Clear cell renal cell carcinoma cells - S100A6 overexpression or knockdown
Clear cell renal cell carcinoma 786-O cells treated with pentamidine
Urinary extracellular vesicles from clear cell renal cell carcinoma patients
Clear cell renal cell carcinoma NRCC cells with FSTL1 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Update on Biomarkers in Renal Cell Carcinoma.
Established and emerging biomarkers of immunotherapy in renal cell carcinoma.
Advanced renal cell carcinoma - an overview of current systemic therapy].
Radiomics and Artificial Intelligence: Renal Cell Carcinoma.
Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Ren…
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA
Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ